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Abstract 1 
Preventing and controlling meticillin-resistant Staphylococcus aureus (MRSA) 2 
includes early detection and isolation.  In the emergency department (ED), such 3 
measures have to be balanced with the requirement to treat patients urgently and 4 
transfer quickly to an acute hospital bed.  We assessed the contribution that previous 5 
MRSA risk group identification and selective rescreening of those patients who were 6 
previously documented in the research hospital as being MRSA positive made to a 7 
patient’s stay in a busy, overcrowded ED. Patients with a previous diagnosis of 8 
MRSA colonisation were flagged automatically as a “risk group” (RG) patient on 9 
their arrival in the ED and were compared with those non-risk group (NRG), i.e. not 10 
previously proven in the research hospital to be infected or colonised with MRSA. 11 
Over an 18 month period, there were 16,456 admissions via the ED of which 985 12 
(6%) were RG patients. The expected median times to be admitted following a request 13 
for a ward bed for NRG and RG patients were 10.4 hours and 12.9 hours, 14 
respectively. Female sex, older age (over 65 years old) and RG status all 15 
independently predicted a statistically significant longer stay in the ED following a 16 
request for a hospital bed. We consider that national and local policies for MRSA 17 
need to balance the welfare of patients in the ED with the need to comply with best 18 
practice, when there are inadequate ED and in-patient isolation facilities. Patients with 19 
MRSA requiring emergency admission must have a bed to go to. 20 
Key words: Emergency department, MRSA, surveillance, isolation, boarders  21 
 22 
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Introduction 1 
Healthcare-associated infection affects 5-10% of patients in an acute hospital, many 2 
of these infections are device-related and meticillin-resistant Staphylococcus aureus 3 
(MRSA) accounts for approximately 16% of all infections.1,2 General infection 4 
prevention and control measures, such as the use of standard precautions, as well as 5 
specific measures for MRSA are justified as the outcome from MRSA infections is 6 
less favourable compared with other infections. A meta-analysis comparing 7 
bloodstream infection due to MRSA and methicillin-susceptible S. aureus showed a 8 
significant increase in mortality associated with MRSA bloodstream infection.3   9 
 10 
Preventing and controlling MRSA requires a multi-faceted approach that includes 11 
early detection and isolation, a common feature of many national guidelines.4   In the 12 
UK and elsewhere, there is a move towards the introduction of universal screening, 13 
i.e. the taking of swabs from all patients irrespective of risk, and this has provoked 14 
some discussion on its merits.5   15 
 16 
In the emergency department (ED), infection prevention and control measures have to 17 
be balanced with the requirement to treat patients urgently and to transfer patients 18 
requiring admission as quickly as possible to acute hospital beds.  Furthermore, in 19 
North America and elsewhere, the phenomenon of community-acquired MRSA is 20 
being seen, particularly in EDs, in patient’s without known risk factors for healthcare-21 
associated MRSA.6 We have documented that anything that prolongs the patient’s ED 22 
stay may adversely affect patient welfare and compound overcrowding.7   Most 23 
national and local guidelines on the prevention and control of MRSA largely focus on 24 
in-patients but their implementation have implications for the ED.  Prolonging a 25 
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patient’s stay in the ED will further compound overcrowding, which is a recognised 1 
contributor to spread of hospital acquired infection.8  2 
 3 
We assessed the contribution that previous MRSA risk group identification and 4 
selective rescreening of these patients made to their stay in a busy, overcrowded ED.  5 
 6 
 7 
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Materials and Methods  1 
Institution and patients 2 
The study was conducted in the ED of an urban academic teaching hospital with an 3 
annual census of approximately 46,000 patient visits, an admission rate of 4 
approximately 23% and an average occupancy with patients awaiting admission 5 
(boarders) of 105%. The observational study was approved by the chair of the 6 
institution’s ethics committee. From the first of November 2006 to the 30th of April 7 
2008, data were gathered in the ED’s Oracle database on all patient attendances that 8 
resulted in admission. This Oracle database was interrogated using the Diver Solution 9 
programme which is a data warehousing solution that facilitates the gathering of data 10 
from different databases.  11 
 12 
Selective screening, involved the taking of swabs from nose, groin and wounds (if 13 
present) from patients at the time of their re-attendance to the ED where there was a 14 
previous positive swab for MRSA in the research hospital. The prior diagnosis of 15 
MRSA colonisation or infection in the research hospital automatically gave rise to the 16 
patients being flagged as a “risk group” (RG) patient on the ED information 17 
technology system. For the purposes of this study the term “risk group” is applied 18 
only to those diagnosed with MRSA in the hospital laboratory on a previous 19 
admission. All such risk group patients were screened for evidence of ongoing MRSA 20 
colonisation. Previous MRSA carriers were declared clear on the basis of three 21 
negative swab results but even those cleared of infection remained as RG on return to 22 
the hospital. 23 
 24 
 25 
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 1 
Patients with a previous diagnosis of MRSA colonisation and / or infection, whether 2 
or not they had negative screens subsequently, were flagged automatically as a “risk 3 
group” (RG) patient on their arrival in the ED using the Oracle database. Those 4 
patients with a prior diagnosis of MRSA colonisation were compared with those 5 
without it with respect to age, sex, triage category, total ED processing time and time 6 
from a bed on a ward being requested until the patient was admitted. Triage is the 7 
systematic prioritisation of patients. The Manchester Triage System uses a series of 8 
criteria to decide what level of priority a patient should have on the basis of their 9 
presentation. The National Triage scale from the United Kingdom is used in many 10 
EDs and is a five point scale from immediate (red), very urgent (orange), urgent 11 
(yellow), standard (green) to non-urgent (blue).9   12 
 13 
The results from all patients screened for MRSA by the hospital’s diagnostic 14 
laboratory were entered on the laboratory information system and this informs the 15 
hospital’s inpatient system at 6 am on the morning following MRSA results being 16 
available. The hospital’s inpatient system informed in turn the Oracle database, and if 17 
the patient subsequently re-attended the ED, that patient was automatically flagged as 18 
a RG patient and selectively screened for evidence of ongoing MRSA colonization. 19 
Previously MRSA positive or RG patients were screened with swabs from the nose, 20 
groin and broken areas of skin, and swabs were cultured on MRSA Select 21 
Chromogenic Agar (Bio-Rad Life Science group, France).  Patients positive for 22 
MRSA were decolonised according to guidelines, and this was commenced in the ED 23 
and continued on hospital wards after admission.10 24 
 25 
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The ED is open plan with fourteen cubicles and two side rooms. Clinically stable 1 
patients with a prior history of MRSA were isolated, where possible in these rooms, 2 
pending the availability of other isolation facilities in the hospital. However, these 3 
side rooms do not have separate toilet facilities or an ante room, and frequently the 4 
number of patients requiring isolation for MRSA and for other indications exceeds the 5 
capacity of the two rooms.  Other patients in the department wait on trolleys or chairs, 6 
usually in close proximity to other patients in the open plan area.  7 
 8 
Statistical analysis 9 
Cox proportional hazards methods were used to evaluate relative probabilities of 10 
being admitted for RG patients versus non-RG patients (NRG) who acted as controls. 11 
The interval time to event analysis determines whether a patient category has an 12 
increased or decreased chance of admittance at a particular time point and the result is 13 
defined by a hazard ratio.   14 
 15 
A multi-factorial model was used to examine if risk group identification was 16 
independently significant in the presence of confounding variables such as age and 17 
sex. In addition the model was stratified into triage categories. Stata (version10, 18 
College Station, Texas) was used to analyse the data and a p value less than 0.05 was 19 
deemed to be significant. 20 
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Results 1 
Over the 18 month period of the study there were 16,456 admissions via the 2 
ED.  Of these, 985 (6%) had a prior diagnosis of MRSA colonisation, i.e. were RG 3 
patients. Amongst the NRG patients, 48.4% were female compared with 45.2% of RG 4 
patients. The Manchester triage category for those who were triaged in RG and NRG 5 
patients are compared in Table 1. Over the time frame of the study 161 of the 16,456  6 
subsequently admitted patients did not undergo triage and are not represented in table 7 
1.  8 
 9 
The total time from arrival in the ED to admission to a ward bed was a median of 20.3 10 
hours. For NRG and RG patients it was a median of 19.9 hours, [IQR 10.5 – 29.8 11 
hours] and 22.6 hours [IQR 12.2 – 33.4 hours], respectively. 12 
 13 
The expected median time to be admitted following a request for a ward bed was 10.5 14 
hours; NRG patients waited a median of 10.4 hours [IQR 3.1 – 20.6 hours] compared 15 
to 12.9 hours [IQR 4.3 – 26.6 hours] for RG patients.  The results of the Cox model 16 
revealed that older age (>65 years old) and female sex were statistically significant 17 
factors influencing the time spent in the ED from arrival to a bed request but MRSA 18 
colonisation was not (Table 2).  However, female sex, older age and RG status all 19 
independently predicted a longer stay in the ED following a request for a hospital bed, 20 
i.e. RG status did not impact on the ED’s and the on-call team’s processing of patients 21 
but did influence the time taken to allocate a ward bed. (Table 2).   22 
 23 
 24 
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Discussion 1 
Risk factors associated with healthcare-associated MRSA infection include advanced 2 
age, male gender, previous hospitalisation, nursing home care, length of 3 
hospitalisation, a stay in intensive care, chronic medical illness, prior antibiotic use, 4 
presence of indwelling devices, asymptomatic colonisation with MRSA and exposure 5 
to an infected or colonised patient.11 In this study we applied the term risk group (RG) 6 
only to those with a prior diagnosis of MRSA colonisation or infection in our hospital 7 
laboratory. All such patients were electronically flagged as RG on their return to the 8 
ED. The flagging of patients with a prior diagnosis of MRSA and selective 9 
rescreening of this group in this study was associated with a prolonged ED stay.  10 
 11 
In the United States it is estimated that the rate of MRSA colonisation in the 12 
community is about 2% of the population.12 Gopal et al found that 6.7% of screened 13 
adult emergency admissions to their UK based hospital were colonised with MRSA.8 14 
It is estimated that a non-isolated MRSA carrier will infect 0.14 patients per day in the 15 
absence of decolonisation.13 Consequently, the early identification of colonized / 16 
infected patients and the prompt implementation of contact precautions are important 17 
in preventing MRSA transmission in hospitals. 8,14-17 18 
 19 
With regards to the limitations of our research the RG status of a patient is not 20 
validated but is assumed to reflect all patients with a previous positive result for 21 
MRSA colonisation in our hospital. The study required the analysis of a real time 22 
computer database which is dependent upon the medical and nursing staff putting in 23 
data in a time sensitive manner. We have no reason to believe that any failure to do so 24 
would have been more prevalent in either those with or without MRSA. 25 
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 1 
Overcrowding in EDs is a distressing and potentially dangerous phenomenon in many 2 
health systems. In our hospital, the elderly, those with prior colonisation with MRSA 3 
and women wait longest for an acute hospital bed when they require emergency 4 
admission. The research hospital has insufficient acute beds to provide for emergency 5 
admissions and this is further compounded by the fact that many patients in the 6 
hospital experience delayed discharges owing to lack of nursing home beds or step 7 
down facilities in the catchment area. The reason for the delay for females may be due 8 
to the fact that our hospital does not usually house males and females in the same bay 9 
of a ward and as more males are admitted as emergencies, finding a “female bed” can 10 
be problematic. The expected time for admission from time of arrival in the ED was a 11 
median of 22.6 hours for RG patients compared to 19.9 hours for NRG patients.  The 12 
additional 2.7 hours for those requiring selective screening and in an individual 13 
patient sick enough to require hospital admission on an already unacceptably long 14 
wait for a hospital bed is of concern and further compounds overcrowding in our ED. 15 
Paradoxically, the implementation of screening to identify patients early who require 16 
isolation or cohorting in hospital impacts negatively on the provision of emergency 17 
care. Overcrowding in EDs has already been shown to increase ambulance diversions 18 
to other units, delay treatments, increase waiting times and walk outs and lead to 19 
longer lengths of hospital stay as well as increasing patient morbidity and mortality.7 20 
 21 
The early identification and recognition of patients with potentially transmissible 22 
diseases and their early isolation is desirable and appropriate as illustrated by the 23 
SARS epidemic earlier this decade.  However, it is neither desirable nor appropriate 24 
that such patients have more prolonged stays in the most overcrowded part of an acute 25 
11 
 
hospital i.e. the ED. Vichard et al argue that “sepsis containment units” where patients 1 
with MRSA can be isolated helps to prevent cross contamination,18  but the ED can 2 
not be expected to house patients for prolonged periods in the absence of isolation 3 
rooms or cohort facilities on wards.  4 
 5 
Dantas et al noted that prolonged stay in the ED posed a risk for colonization and the 6 
transmission of multidrug-resistant bacteria and for contracting HCAI, all associated 7 
with increased mortality. 19  Cunningham et al documented that overcrowding and the 8 
rapid turnover of patients in acute hospital settings contributes to cross-infection with 9 
MRSA and they argue that adequate acute capacity would help to address this.20  Borg 10 
has described the correlation between workload indices and increased HCAI.21  11 
 12 
The results of the study reported here show that the selective screening of patients 13 
with a prior diagnosis of MRSA colonisation prolongs their ED stay and increases the 14 
workload of already busy ED nursing staff, potentially increasing MRSA 15 
transmission. Reducing overcrowding in neonatal intensive care units has been shown 16 
to be effective in controlling endemic MRSA spread22  and it is plausible that reducing 17 
ED overcrowding would have a similar positive effect.  18 
 19 
The delay in being admitted to a ward bed from the ED in this study has been shown 20 
to be partly related to selective screening for MRSA.  Being over 65 years old, being 21 
female or having MRSA should not mean that the patient will have a longer wait in 22 
the ED when they require acute admission. Being able to clarify the patients MRSA 23 
status sooner would probably help to facilitate earlier transfer to a bed. PCR testing 24 
for MRSA may be of benefit in this regard. Hospital ward staff are reluctant to accept 25 
12 
 
patients from our ED with MRSA without there being an isolation room available 1 
because of the risk of cross-infection. Clearly, leaving patients for prolonged periods 2 
in the ED which is the most overcrowded part of any acute hospital is not appropriate. 3 
Acute hospitals must accept that factors contributing to the spread of infection are 4 
important on in-patient wards and in the ED. Having identified the problem the 5 
research hospital has now allocated areas within each ward that allow for the setting 6 
up of cohorts of patients with MRSA, if no single rooms are available. Another 7 
alternative suggestion is to not selectively screen patients during the ED component of 8 
their hospital stay if in so doing ward placement is made more difficult and to allow 9 
patients to be screened on the wards.  10 
 11 
Harbarth et al investigated the use of a universal rapid MRSA admission screening in 12 
a surgical department and although they did not demonstrate a reduction in 13 
nosocomial MRSA, they acknowledge that others have recommended universal 14 
admission screening as a means to control MRSA.23-25  Robiecsek et al in their study 15 
of universal admission MRSA surveillance with isolation and decolonization of 16 
patients who tested positive for MRSA, found that this was associated with a greater 17 
than 50% reduction in healthcare–associated MRSA bloodstream, respiratory, urinary 18 
tract and surgical site infections during admission and for up to 30 days after 19 
discharge.26 20 
 21 
The early isolation of patients with MRSA is the standard in most centres but 22 
adequate facilities must be available both on hospital wards and in EDs.  We have 23 
shown that selective screening of patients with a prior diagnosis of MRSA 24 
colonisation in our hospital prolongs the wait for an acute hospital bed and 25 
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compounds ED overcrowding.  National and local policies for MRSA control need to 1 
address this by balancing the welfare of patients in the ED with the need to comply 2 
with best practice when there are inadequate ED and in-patient isolation facilities. 3 
Patients with MRSA requiring emergency admission to hospital must have a bed to go 4 
to. 5 
 6 
We are grateful to all the staff in the ED and the infection prevention and control team. 7 
14 
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Table 1. Triage categories of admitted patients from the ED with and without MRSA.  1 
 2 
Category  Immediate 
(Red) 
Very urgent 
(Orange) 
Urgent 
(Yellow) 
Standard 
(Green) 
Non-urgent 
(Blue) 
NRG 
 (%) 
171 
(1.1 ) 
5936 
(38.8 ) 
8864 
(57.9 ) 
322 
(2.1 ) 
25 
(.2 ) 
RG 
(%) 
18 
(1.8 ) 
459 
(47 ) 
489 
(50.1 ) 
10 
(1 ) 
1 
(.1 ) 
NRG = Non-risk Group (not previously MRSA positive), 3 
RG = Risk Group (previously MRSA positive). 4 
 5 
17 
 
Table 2.    Cox model of variables associated with prolonged ED stay from time of 1 
arrival to time of hospital admission. 2 
 3 
 4 
 5 
 
 
 
Variable 
  Hazard ratio 
  from time of arrival to 
  bed request 
   [95% CI] 
Hazard ratio 
from bed request to 
admission  
[95% CI] 
  
RG 
Age > 65 years 
Female Sex 
0.946      [0.887  -  1.010]* 
0.891      [0.863  -  0.919]** 
0.902      [0.875  -  0.930]** 
0.874      [0.819  -  0.933]** 
0.780      [0.756  -  0.805]** 
0.883      [0.857  -  0.911]** 
 6 
RG, Risk group, i.e. previously MRSA positive 7 
*p = 0.094 8 
** p <0.001 9 
 10 
 11 
 12 
 13 
